Many authors found that cancer stem cells expressing CD44 in lung cancer tissues, breast and colorectal cancer cell lines have high expressions of PD-L1 on their surface compared to CD44 negative populations [13, 61]. This evidence concerns the gene CD44 and colorectal cancer.